Covalent probes have emerged as a pivotal tool in drug discovery, presenting unique challenges for integrating structural data compared to non-covalent probes. Here, the authors explore the role of structure-based design in optimizing covalent probes, emphasizing computational methods to harness structural insights, potentially transforming drug design strategies across various fields.
- Matthew Holcomb
- Manuel Llanos
- Stefano Forli